de Almeida Danilo Candido, Evangelista Laura Sibele Martins, Câmara Niels Olsen Saraiva
Department of Medicine, Nephrology Division, Federal University of São Paulo, São Paulo, SP 04039-003, Brazil.
World J Stem Cells. 2017 Sep 26;9(9):152-158. doi: 10.4252/wjsc.v9.i9.152.
Mesenchymal stromal cells (MSCs) possess great therapeutic advantages due to their ability to produce a diverse array of trophic/growth factors related to cytoprotection and immunoregulation. MSC activation specific receptors is a crucial event for these cells to exert their immunosuppressive response. The aryl-hydrocarbon receptor (AhR) is a sensitive molecule for external signals and it is expressed in MSCs and, upon positive activation, may potentially regulate the MSC-associated immunomodulatory function. Consequently, signalling pathways linked to AhR activation can elucidate some of the molecular cascades involved in MSC-mediated immunosuppression. In this minireview, we have noted some important findings concerning MSC regulation AhR, highlighting that its activation is associated with improvement in migration and immunoregulation, as well as an increase in pro-regenerative potential. Thus, AhR-mediated MSC activation can contribute to new perspectives on MSC-based therapies, particularly those directed at immune-associated disorders.
间充质基质细胞(MSCs)因其能够产生多种与细胞保护和免疫调节相关的营养/生长因子而具有巨大的治疗优势。MSCs激活特定受体是这些细胞发挥免疫抑制反应的关键事件。芳烃受体(AhR)是一种对外部信号敏感的分子,它在MSCs中表达,在被正向激活后,可能潜在地调节与MSCs相关的免疫调节功能。因此,与AhR激活相关的信号通路可以阐明一些参与MSCs介导的免疫抑制的分子级联反应。在这篇小型综述中,我们注意到了一些关于MSCs受AhR调节的重要发现,强调其激活与迁移和免疫调节的改善以及促再生潜能的增加有关。因此,AhR介导的MSCs激活可以为基于MSCs的治疗提供新的视角,特别是针对免疫相关疾病的治疗。